Zobrazeno 1 - 10
of 182
pro vyhledávání: '"Wang, Yu Dong"'
Publikováno v:
Zhongguo linchuang yanjiu, Vol 36, Iss 11, Pp 1655-1658 (2023)
Objective To evaluate the application and value of nanocarbon tracer in the surgical treatment of papillary thyroid microcarcinoma (PTMC). Methods Retrospective analysis of clinical and pathological data of 165 PTMC patients who underwent thyroid can
Externí odkaz:
https://doaj.org/article/acdd71b6c2d74b1c8314501681d30ad1
Publikováno v:
In Chemical Physics Letters December 2023 832
Autor:
Song, Fang-Jiao, Liu, Hong-Ling, Sun, Ying, Xu, Tian-Jiao, Li, Dong-Ze, Wang, Hai-Bo, Xin, Shao-Jie, Wang, Yu-Dong, Cheng, Gregory, Lau, George, Lv, Sa, You, Shao-Li, Zhu, Bing
Publikováno v:
In iLIVER September 2023 2(3):156-162
Up to the next-leading order (NLO) of quantum chromodynamics (QCD), the process $e^+e^-\to J/\psi +X$ with the center-of-mass (CM) energy range from 3.7 to 10.6 GeV is calculated. At 10.6 GeV, the results is consistent with the experiment results at
Externí odkaz:
http://arxiv.org/abs/1903.08161
Publikováno v:
In Clinical Neurology and Neurosurgery February 2023 225
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Wang, Yu-Dong, Wang, Jian-Xiong
At designed CEPC, similar to hadron collider, the angular distribution coefficients of decay lepton pair from produced Z(W) boson in $e^+ e^-$ collisions are predicted. Their dependence on $cos\theta_Z$($cos\theta_W$) are presented in four different
Externí odkaz:
http://arxiv.org/abs/1812.09845
Autor:
MAO, Chen-Chen, HU, Qi, NING, Yi-Ming, ZHANG, Da-Jin, GAO, Yu-Kun, XU, Xiang-Yan, WANG, Yu-Dong, SHI, Mei-Yun, MA, Qiang, XUE, Hong-Yu
Publikováno v:
In Chinese Journal of Analytical Chemistry November 2022 50(11)
Autor:
Xu, Nengneng, Wilson, Joshua A., Wang, Yu-Dong, Su, Tianshun, Wei, Yanan, Qiao, Jinli *, Zhou, Xiao-Dong **, Zhang, Yanxing ***, Sun, Shuhui
Publikováno v:
In Applied Catalysis B: Environment and Energy 5 September 2020 272
Publikováno v:
Open Medicine, Vol 15, Iss 1, Pp 589-597 (2020)
This study evaluates the efficacy and safety of bevacizumab (BEV) in the treatment of non-small cell lung cancer (NSCLC) patients with brain metastases (BM) by performing meta-analyses of response and survival indices. Seventeen studies were included
Externí odkaz:
https://doaj.org/article/dfc97b890f174a85aac74dbf806bc6c2